Association between serum uric acid levels and atrial fibrillation in different fasting glucose patterns: A case-control study

Front Endocrinol (Lausanne). 2023 Jan 23:14:1021267. doi: 10.3389/fendo.2023.1021267. eCollection 2023.

Abstract

Background: Previous studies have shown both dysglycaemia and hyperuricemia are associated with an increased risk of atrial fibrillation (AF), while the relationship between serum uric acid (SUA) levels and AF in different fasting glucose patterns (FBG) is unclear. Therefore, this study aimed to determine the association between SUA and AF in different FBG patterns.

Methods: A total of 1840 patients in this case-control study were enrolled, including 920 AF patients and 920 controls. Patients were divided into three groups according to the different FBG patterns: normoglycemic, impaired fasting glucose (IFG), and diabetes mellitus (DM). Multivariate logistic regression models were performed to evaluate the relationship between SUA and AF in different FBG patterns. Pearson correlation analysis was used to explore the correlation between SUA and metabolic factors. Receiver operating characteristic (ROC) curve models indicated the diagnostic efficiency of SUA for diagnosing AF.

Results: SUA was independently associated with AF after adjusting for all confounding factors in different FBG patterns(normoglycemic: OR=1.313, 95% CI:1.120-1.539; IFG: OR=1.386, 95% CI:1.011-1.898; DM: OR=1.505, 95% CI:1.150-1.970). Pearson's correlation analysis suggested that SUA in AF patients was correlated with several different metabolic factors in different FBG patterns (p<0.05). ROC curve analysis showed that SUA in the normoglycemic group combined with CHD and APOB [AUC: 0.906 (95% CI: 0.888-0.923)], in the IFG group combined with CHD and Scr [AUC: 0.863 (95% CI: 0.820-0.907)], in the DM group combined with CHD and SBP [AUC: 0.858 (95% CI: 0.818-0.898)] had the highest AUC for predicting AF.

Conclusion: Findings implied a significant association between SUA and AF in different FBG patterns and provide specific models combined with other factors (CHD, APOB, SCr, SBP), which might contribute to the diagnosis of AF.

Keywords: atrial fibrillation; diabetes mellitus; glucose metabolism; inflammation; serum uric acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins B
  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / etiology
  • Case-Control Studies
  • Fasting
  • Glucose
  • Humans
  • Risk Factors
  • Uric Acid

Substances

  • Uric Acid
  • Glucose
  • Apolipoproteins B

Grants and funding

This study was supported by Key Research and Development Program of Shandong Province, Major Science and Technology Innovation Project of China (NO. 2021SFGC0503).